featured
Perioperative Nivolumab for Resectable Stage IIA–IIIB NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Perioperative Nivolumab in Resectable Lung Cancer
N. Engl. J. Med 2024 May 16;390(19)1756-1769, T Cascone, MM Awad, JD Spicer, J He, S Lu, B Sepesi, F Tanaka, JM Taube, R Cornelissen, L Havel, N Karaseva, J Kuzdzal, LB Petruzelka, L Wu, JL Pujol, H Ito, TE Ciuleanu, L de Oliveira Muniz Koch, A Janssens, A Alexandru, S Bohnet, FV Moiseyenko, Y Gao, Y Watanabe, C Coronado Erdmann, P Sathyanarayana, S Meadows-Shropshire, SI Blum, M Provencio PullaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.